Navigation Links
Factor Xa Protease from QIAGEN

ProductsFactor Xa Protease from QIAGEN
Company QIAGEN
Item Factor Xa Protease
Price 
Description 
  • For cleavage of 6xHis tags from proteins containing a Factor Xa Protease recognition site
  • Efficient 6xHis tag cleavage (greater than 90%)
Info QIAGENQIAGEN
USA - QIAGEN Inc.
27220 Turnberry Lane
Valencia, CA 91355
Orders: 800-426-8157
Fax: 800-718-2056
Technical: 800-DNA-PREP
(800-362-7737)

Germany - QIAGEN GmbH
QIAGEN Strae 1
40724 Hilden
Orders: 02103-29-12000
Fax: 02103-29-22000
Technical: 02103-29-12400

QIAGEN worldwide contacts:
http://www.qiagen.com/qiagenww.asp

Customer Service: 800-426-8157
Tech Support: 800-362-7737
Fax Number: 800-718-2056
Web Site: http://www.qiagen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Human / Mouse / Rat Blood Vessels (CD31 / Von Willebrand Factor (vWF)) IHC staining Kit from CHEMICON
2. Factor B-depleted serum from Quidel
3. LN2 Backup, Factory Installed, All Voltages, for 3.0 and 6.7 cu ft -86C Chest Freezers & all -40C/ -86C Upright Freezers from Thermo Scientific
4. Deluxe CO2 Backup, Factory Installed, All Voltages, for 3.0 and 6.7 cu ft -86C Chest Freezers & all -40C/ -86C Upright Freezers from Thermo Scientific
5. Anti-Factor XIIIa Ab-2 Polyclonal Antibody, Unconjugated from Lab Vision
6. Human Granulocyte Macrophage Colony Stimulating Factor, Unconjugated from PeproTech
7. Anti-Rheumatoid Factor Monoclonal Antibody, Unconjugated from QED Bioscience Inc.
8. Mouse Anti-Human ADP-Ribosylation Factor 1 Monoclonal Antibody, Unconjugated, Clone 3F1 from CHEMICON
9. Basement Membrane Extract Reduced Growth Factor from R&D Systems
10. Mouse Anti-Factor V Heavy Chain Monoclonal Antibody, Unconjugated from GeneTex
11. Sheep Anti-Human Factor XIII Antibody, Horseradish Peroxidase Conjugated from CEDARLANE Laboratories Limited
(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has ... Strategic Business Report" report to their offering. ... US$ Thousands. The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... Latin America . Annual estimates and forecasts ...
(Date:3/17/2015)... 17, 2015 MedNet Solutions , ... clinical study management systems, is pleased to announce ... ARENA,s Outsourcing in Clinical Trials Southeast conference – ... an excellent forum for MedNet to showcase ... software-as-a-service (SaaS) eClinical technology platform. We ...
(Date:3/16/2015)... March 16, 2015 Between ... will present groundbreaking innovations in biometric identification at ... .      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ... innovation is well at the forefront: the company,s ... made in Germany . BiometricGate ...
Breaking Biology News(10 mins):Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3
... in Denmark revealed that increasing levels of non-fasting triglycerides ... in men and women. Higher cholesterol levels were associated ... this novel, 33-year study are now available online in ... Wiley-Blackwell on behalf of the American Neurological Association. ...
... decoded the DNA of the parasitic worm that causes ... pork or carnivorous wild game animals, such as bear ... Washington University School of Medicine in St. Louis and ... the parasite, Trichinella spiralis , which provide potential ...
... to different climates and diets as they split off from other ... for humans living today? A panel of scholars from ... Sunday February 20th at the AAAS meeting in Washington, DC, as ... at Work In Humans and Their Relatives." The speakers ...
Cached Biology News:Increasing triglyceride levels linked to greater stroke risk 2Trichinosis parasite gets DNA decoded 2Panelists to discuss evolution of human brain size, skin color and diet at AAAS meeting 2
(Date:4/16/2015)... (PRWEB) April 16, 2015 Capillus, ... distribution and physician network in Europe and Asia. ... has appointed Fernando Bermúdez, former Business Development Director ... An industry veteran, Mr. Bermúdez’s professional achievements include ... in Spain, while also penetrating the Portuguese marketplace ...
(Date:4/16/2015)... OncoTAb, Inc., a ... spin-out company, announced today the appointment of physician ... Chief Operating Officer (COO). Cooper brings to OncoTAb ... clinical diagnostic and biotechnology platforms in the fields ... extensive career transcends the field of medical and ...
(Date:4/16/2015)... 2015 /CNW/ - Bioenterprise Corporation is pleased to announce that ... Charlottetown , PEI.  Bioenterprise has established a ... Council for the commercialization of agricultural technologies and innovations. ... PEI ADAPT.  They have been at the heart of ... explains Dave Smardon , President & CEO of ...
(Date:4/16/2015)... -- Avelas Biosciences, an in vivo cancer ... that it has initiated a Phase 1b study of ... primary, non-recurrent breast cancer undergoing surgery. In commencing the ... Steven Chen , M.D., as vice president of ... study will enroll up to 39 women with stage ...
Breaking Biology Technology:Capillus, LLC Extends Laser Hair Therapy Products to Europe and Asia 2OncoTAb Names Dr. David L. Cooper as COO 2Bioenterprise Corporation Expands into the Maritimes 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3